🚀 VC round data is live in beta, check it out!
Exact Therapeutics Valuation Multiples
Discover revenue and EBITDA valuation multiples for Exact Therapeutics and similar public comparables like Biofrontera, Quantum BioPharma, Wellgistics Health, Anebulo Pharmaceuticals and more.
Exact Therapeutics Overview
About Exact Therapeutics
Exact Therapeutics AS is a clinical-stage biotechnology company. It is developing Acoustic Cluster Therapy (ACT), a non-invasive precision health technology for targeted enhancement of therapeutics. ACT sonoporation is an approach to ultrasound-mediated, targeted drug enhancement that will amplify the clinical utility of therapeutic agents across a multitude of indications including within oncology (chemotherapy, immunotherapy), infectious diseases, and neurological conditions.
Founded
2012
HQ
Employees
12
Website
Sectors
Financials (FY)
EV
$16M
Exact Therapeutics Financials
Exact Therapeutics reported last fiscal year revenue of — and negative EBITDA of ($9M).
In the same fiscal year, Exact Therapeutics generated ($9M) in EBITDA losses and had net loss of ($9M).
Exact Therapeutics P&L
In the most recent fiscal year, Exact Therapeutics reported revenue of — and EBITDA of ($9M).
Exact Therapeutics expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| EBITDA | — | XXX | ($9M) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($9M) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Exact Therapeutics Stock Performance
Exact Therapeutics has current market cap of $18M, and enterprise value of $16M.
Market Cap Evolution
Exact Therapeutics' stock price is $0.16.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $16M | $18M | -0.4% | XXX | XXX | XXX | $-0.08 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialExact Therapeutics Valuation Multiples
Exact Therapeutics trades at (1.8x) EV/EBITDA.
Exact Therapeutics Financial Valuation Multiples
As of April 18, 2026, Exact Therapeutics has market cap of $18M and EV of $16M.
Equity research analysts estimate Exact Therapeutics' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Exact Therapeutics has a P/E ratio of (2.0x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $18M | XXX | $18M | XXX | XXX | XXX |
| EV (current) | $16M | XXX | $16M | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (1.8x) | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (1.7x) | XXX | XXX | XXX |
| P/E | — | XXX | (2.0x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (2.0x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Exact Therapeutics Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Exact Therapeutics Margins & Growth Rates
Exact Therapeutics' revenue in the last fiscal year grew by —.
Exact Therapeutics' revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.8M for the same period.
Exact Therapeutics Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| EBITDA Growth | — | XXX | 67% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.8M | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Exact Therapeutics Public Comps
See public comps and valuation multiples for other Biopharmaceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Exact Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| Biofrontera | XXX | XXX | XXX | XXX | XXX | XXX |
| Quantum BioPharma | XXX | XXX | XXX | XXX | XXX | XXX |
| Wellgistics Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Anebulo Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
| Lipocine | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Exact Therapeutics M&A Activity
Exact Therapeutics acquired XXX companies to date.
Last acquisition by Exact Therapeutics was on XXXXXXXX, XXXXX. Exact Therapeutics acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Exact Therapeutics
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialExact Therapeutics Investment Activity
Exact Therapeutics invested in XXX companies to date.
Exact Therapeutics made its latest investment on XXXXXXXX, XXXXX. Exact Therapeutics invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Exact Therapeutics
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Exact Therapeutics
| When was Exact Therapeutics founded? | Exact Therapeutics was founded in 2012. |
| Where is Exact Therapeutics headquartered? | Exact Therapeutics is headquartered in Norway. |
| How many employees does Exact Therapeutics have? | As of today, Exact Therapeutics has over 12 employees. |
| Is Exact Therapeutics publicly listed? | Yes, Exact Therapeutics is a public company listed on Oslo Børs. |
| What is the stock symbol of Exact Therapeutics? | Exact Therapeutics trades under EXTX ticker. |
| When did Exact Therapeutics go public? | Exact Therapeutics went public in 2020. |
| Who are competitors of Exact Therapeutics? | Exact Therapeutics main competitors are Biofrontera, Quantum BioPharma, Wellgistics Health, Anebulo Pharmaceuticals. |
| What is the current market cap of Exact Therapeutics? | Exact Therapeutics' current market cap is $18M. |
| Is Exact Therapeutics profitable? | No, Exact Therapeutics is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.